In lung adenocarcinomas, IL32 is highly expressed in both tumor cells and infiltrating leukocytes leading investigators to suggest that both the lung tumor cells and tumor infiltrating leukocytes are involved in tumor progression. The gene discussed is IL32; the disease is neoplasm.